Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy

Enrolling by invitationOBSERVATIONAL
Enrollment

1,432

Participants

Timeline

Start Date

July 14, 2011

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Breast CancerLymphoma
Trial Locations (29)

13057

Hem Onc CNY, East Syracuse

14642

Kansas City, Rochester

University of Rochester Cancer Center, Rochester

19713

Delaware/Christiana Care NCORP, Newark

19718

Delaware/Christiana Care NCORP (CHRISTIANA), Newark

27103

Novant Health Cancer Institute - Kernersville, Winston-Salem

27104

Southeast Clinical Oncology Research Program, Winston-Salem

29303

Upstate Carolina, Spartanburg

29605

NCORP of the Carolinas, Greenville

43215

Columbus NCORP, Columbus

Columbus, Columbus

45420

Dayton Community Oncology Program, Dayton

45459

Dayton, Dayton

49503

Cancer Research Consortium of West Michigan, Grand Rapids

CRCWM, Grand Rapids

53226

Aurora NCORP, Milwaukee

54449

Wisconsin NCORP, Marshfield

55416

Metro Minnesota Community Oncology Research Consortium, Saint Louis Park

55426

Metro Minnesota NCORP, Minneapolis

62526

Heartland, Decatur

66208

Kansas City Clinical Oncology Program, Prairie Village

67214

Wichita NCORP, Wichita

Wichita, Wichita

70112

Gulf South MU-NCORP, New Orleans

89106

CCOP - Nevada Cancer Research Foundation, Las Vegas

Nevada, Las Vegas

97213

Pacific Cancer Research Consortium Ncorp, Portland

PCRC, Portland

98101

Northwest (Virginia Mason), Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Rochester NCORP Research Base

OTHER